Modular Medical Announces Completion of Clinical Study of MODD1 Pump

Core Insights - Modular Medical, Inc. has successfully completed a clinical study with its MODD1 pump, which is designed for Type 1 diabetes patients [1] - The MODD1 pump targets the estimated $3 billion adult "almost-pumpers" market with a user-friendly and affordable design [1] - The study involved nine clinicians who currently use continuous glucose monitors and other pumps, providing valuable real-world feedback for product refinement [1] Company Overview - Modular Medical specializes in insulin delivery technology and has developed the first FDA-cleared patch pump specifically for Type 1 diabetes [1] - The company is preparing for the launch of its next-generation Pivot pump product based on insights gained from the clinical study [1] Market Context - The adult "almost-pumpers" market is estimated to be worth $3 billion, indicating significant potential for growth in insulin delivery solutions [1] - The successful completion of the clinical study positions Modular Medical to capitalize on this market opportunity with its innovative product offerings [1]